GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » Price-to-Owner-Earnings

Decipher Labs (BOM:524752) Price-to-Owner-Earnings : 5.49 (As of May. 24, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs Price-to-Owner-Earnings?

As of today (2024-05-24), Decipher Labs's share price is ₹14.93. Decipher Labs's Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹2.72. It's Price-to-Owner-Earnings for today is 5.49.


The historical rank and industry rank for Decipher Labs's Price-to-Owner-Earnings or its related term are showing as below:

BOM:524752' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.11   Med: 48.69   Max: 203.63
Current: 5.48

During the past 13 years, the highest Price-to-Owner-Earnings of Decipher Labs was 203.63. The lowest was 3.11. And the median was 48.69.


BOM:524752's Price-to-Owner-Earnings is ranked better than
93.56% of 419 companies
in the Drug Manufacturers industry
Industry Median: 27.45 vs BOM:524752: 5.48

As of today (2024-05-24), Decipher Labs's share price is ₹14.93. Decipher Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-194.94. Therefore, Decipher Labs's PE Ratio for today is At Loss.

As of today (2024-05-24), Decipher Labs's share price is ₹14.93. Decipher Labs's EPS without NRI for the trailing twelve months (TTM) ended in was ₹-192.26. Therefore, Decipher Labs's PE Ratio without NRI for today is At Loss.

During the past 13 years, Decipher Labs's highest PE Ratio without NRI was 137.00. The lowest was 0.00. And the median was 23.97.


Decipher Labs Price-to-Owner-Earnings Historical Data

The historical data trend for Decipher Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs Price-to-Owner-Earnings Chart

Decipher Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.17 - 173.32 4.02 5.21

Decipher Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.21 - - -

Competitive Comparison of Decipher Labs's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Decipher Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decipher Labs's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Decipher Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Decipher Labs's Price-to-Owner-Earnings falls into.



Decipher Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Decipher Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=14.93/2.72
=5.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs  (BOM:524752) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Decipher Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Decipher Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs (BOM:524752) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs (BOM:524752) Headlines

No Headlines